An Analytics Approach to Guide Randomized Controlled Trials in Hypertension Management

Published Online:https://doi.org/10.1287/mnsc.2021.4226

References

  • Akoglu H (2018) User’s guide to correlation coefficients. Turkish J. Emergency Medicine 18(3):91–93.CrossrefGoogle Scholar
  • Alagoz O, Maillart LM, Schaefer AJ, Roberts MS (2004) The optimal timing of living-donor liver transplantation. Management Sci. 50(10):1420–1430.LinkGoogle Scholar
  • Ayer T, Alagoz O, Stout NK (2012) OR forum—A POMDP approach to personalize mammography screening decisions. Oper. Res. 60(5):1019–1034.LinkGoogle Scholar
  • Bangalore S, Messerli FM, Wun CC, Zuckerman AL, DeMicco D, Kostis JB, LaRosa JC, Treating to New Targets Steering Committee and Investigators (2010) J-curve revisited: An analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) trial. Eur. Heart J. 31(23):2897–2908.CrossrefGoogle Scholar
  • Bastani H, Bayati M (2020) Online decision making with high-dimensional covariates. Oper. Res. 68(1):276–294.LinkGoogle Scholar
  • Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, Stoyanovsky V, et al. (2008) Treatment of hypertension in patients 80 years of age or older. New England J. Medicine 358(18):1887–1898.CrossrefGoogle Scholar
  • Bertsimas D, O’Hair A, Relyea S, Silberholz J (2016) An analytics approach to designing combination chemotherapy regimens for cancer. Management Sci. 62(5):1511–1531.LinkGoogle Scholar
  • Bjarnadottir M, Anderson D, Zia L, Rhoads K (2018) Predicting colorectal cancer mortality: Models to facilitate patient-physician conversations and inform operational decision making. Production Oper. Management 27(12):2162–2183.CrossrefGoogle Scholar
  • Choudhry NK, Patrick AR, Antman EM, Avorn J, Shrank WH (2008) Cost-effectiveness of providing full drug coverage to increase medication adherence in post–myocardial infarction Medicare beneficiaries. Circulation 117(10):1261–1268.CrossrefGoogle Scholar
  • Chrysant SG (2020) The clinical significance of isolated diastolic hypertension. Postgraduate Medicine 132(7):624–628.CrossrefGoogle Scholar
  • Corrao G, Mazzola P, Compagnoni MM, Rea F, Merlino L, Annoni G, Mancia G (2015) Antihypertensive medications, loop diuretics, and risk of hip fracture in the elderly: A population-based cohort study of 81,617 Italian patients newly treated between 2005 and 2009. Drugs Aging 32(11):927–936.CrossrefGoogle Scholar
  • Cutler DM, Long G, Berndt ER, Royer J, Fournier AA, Sasser A, Cremieux P (2007) The value of antihypertensive drugs: A perspective on medical innovation. Health Affairs 26(1):97–110.CrossrefGoogle Scholar
  • D’Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB (2008) General cardiovascular risk profile for use in primary care: The Framingham Heart Study. Circulation 117(6):743–753.CrossrefGoogle Scholar
  • Denardo SJ, Gong Y, Nichols WW, Messerli FH, Bavry AA, Cooper-DeHoff RM, Handberg EM, Champion A, Pepine CJ (2010) Blood pressure and outcomes in very old hypertensive coronary artery disease patients: An INVEST substudy. Amer. J. Medicine 123(8):719–726.CrossrefGoogle Scholar
  • Denton BT, Kurt M, Shah ND, Bryant SC, Smith SA (2009) Optimizing the start time of statin therapy for patients with diabetes. Medical Decision Making 29(3):351–367.CrossrefGoogle Scholar
  • Divine MR, Katiyar P, Kohlhofer U, Quintanilla-Martinez L, Pichler BJ, Disselhorst JA (2016) A population-based Gaussian mixture model incorporating 18F-FDG PET and diffusion-weighted MRI quantifies tumor tissue classes. J. Nuclear Medicine 57(3):473–479.CrossrefGoogle Scholar
  • Epstein CL (2014) An analytics approach to hypertension treatment. Unpublished PhD thesis, Massachusetts Institute of Technology, Cambridge, MA.Google Scholar
  • Fang J, Madhavan S, Cohen H, Alderman MH (1995) Isolated diastolic hypertension: A favorable finding among young and middle-aged hypertensive subjects. Hypertension 26(3):377–382.CrossrefGoogle Scholar
  • Franklin SS, Lopez VA, Wong ND, Mitchell GF, Larson MG, Vasan RS, Levy D (2009) Single vs. combined blood pressure components and risk for cardiovascular disease. Circulation 119(2):243–250.CrossrefGoogle Scholar
  • Go AS, Bauman MA, Coleman King SM, Fonarow GC, Lawrence W, Williams KA, Sanchez E (2014) An effective approach to high blood pressure control: A science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. J. Amer. College Cardiology 63(12):1230–1238.CrossrefGoogle Scholar
  • Hentati-Kaffel R, Prigent JL (2016) Optimal positioning in financial derivatives under mixture distributions. Econom. Model. 52(A):115–124.CrossrefGoogle Scholar
  • Ibrahim R, Kucukyazici B, Verter V, Gendreau M, Blostein M (2015) Designing personalized treatment: An application to anticoagulation therapy. Production Oper. Management 25(5):902–918.CrossrefGoogle Scholar
  • James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, et al. (2014) 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311(5):507–520.CrossrefGoogle Scholar
  • Kannel WB, Gordon T, Schwartz MJ (1971) Systolic vs. diastolic blood pressure and risk of coronary heart disease: The Framingham study. Amer. J. Cardiology 27(4):335–346.CrossrefGoogle Scholar
  • Katz RW, Parlange MB (1996) Mixtures of stochastic processes: Application to statistical downscaling. Climate Res. 7(2):185–193.CrossrefGoogle Scholar
  • Kodinariya TM, Makwana PR (2013) Review on determining number of cluster in k-means clustering. Internat. J. Adv. Res. Comput. Sci. Management Stud. 1(6):90–95.Google Scholar
  • Kovesdy CP, Bleyer AJ, Molnar MZ, Ma JZ, Sim JJ, Cushman WC, Quarles LD, Kalantar-Zadeh K (2013) Blood pressure and mortality in U.S. veterans with chronic kidney disease: A cohort study. Ann. Internal Medicine 159(4):233–242.CrossrefGoogle Scholar
  • Kuha J (2004) AIC and BIC: Comparisons of assumptions and performance. Sociol. Methods Res. 33(2):188–229.CrossrefGoogle Scholar
  • Kurt M, Denton BT, Schaefer AJ, Shah ND, Smith SA (2011) The structure of optimal statin initiation policies for patients with type 2 diabetes. IIE Trans. Healthcare. Systems Engrg. 1(1):49–65.CrossrefGoogle Scholar
  • Law MR, Morris JK, Wald NJ (2009) Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 338:b1665.CrossrefGoogle Scholar
  • Lemenuel-diot A, Laveille C, Frey N, Jochemsen R, Mallet A (2007) Mixture modeling for the detection of subpopulations in a pharmacokinetic/pharmacodynamic analysis. J. Pharmacokinetics Pharmacodynamics 34(2):157–181.CrossrefGoogle Scholar
  • Mason JE, Denton BT, Shah ND, Smith SA (2014) Optimizing the simultaneous management of blood pressure and cholesterol for type 2 diabetes patients. Eur. J. Oper. Res. 233(3):727–738.CrossrefGoogle Scholar
  • Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, et al. (2016) Executive summary: Heart disease and stroke statistics—2016 update: A report from the American Heart Association. Circulation 133(4):447–454.Google Scholar
  • Negoescu DM, Bimpikis K, Brandeau ML, Iancu DA (2017) Dynamic learning of patient response types: An application to treating chronic diseases. Management Sci. 64(8):3469–3488.LinkGoogle Scholar
  • Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y (2005) Prognosis of “masked” hypertension and “white-coat” hypertension detected by 24-h ambulatory blood pressure monitoring: 10-year follow-up from the Ohasama study. J. Amer. College Cardiology 46(3):508–515.CrossrefGoogle Scholar
  • Parati G, Ochoa JE, Lombardi C, Bilo G (2013) Assessment and management of blood-pressure variability. Nature Rev. Cardiology 10(3):143–155.CrossrefGoogle Scholar
  • Pastor-Barriuso R, Banegas JR, Damin J, Appel LJ, Guallar E (2003) Systolic blood pressure, diastolic blood pressure, and pulse pressure: An evaluation of their joint effect on mortality. Ann. Internal Medicine 139(9):731–739.CrossrefGoogle Scholar
  • Reynolds D (2009) Gaussian mixture models. Li SZ, Jain A, eds. Encyclopedia of Biometrics (Springer, Boston), 659–663.CrossrefGoogle Scholar
  • Sabouri A, Huh WT, Shechter SM (2017) Screening strategies for patients on the kidney transplant waiting list. Oper. Res. 65(5):1131–1146. 10.1287/opre.2017.1632LinkGoogle Scholar
  • Sandikçi B, Maillart LM, Schaefer AJ, Alagoz O, Roberts MS (2008) Estimating the patient’s price of privacy in liver transplantation. Oper. Res. 56(6):1393–1410.LinkGoogle Scholar
  • Schell GJ (2015) Personalized medicine in chronic disease management. Unpublished PhD thesis, University of Michigan, Ann Arbor, MI.Google Scholar
  • Shechter SM, Bailey MD, Schaefer AJ, Roberts MS (2008) The optimal time to initiate HIV therapy under ordered health states. Oper. Res. 56(1):20–33.LinkGoogle Scholar
  • Sim JJ, Shi J, Kovesdy CP, Kalantar-Zadeh K, Jacobsen SJ (2014) Impact of achieved blood pressures on mortality risk and end-stage renal disease among a large, diverse hypertension population. J. Amer. College Cardiology 64(6):588–597.CrossrefGoogle Scholar
  • Skandari MR, Shechter SM, Zalunardo N (2015) Optimal vascular access choice for patients on hemodialysis. Manufacturing Service Oper. Management 17(4):608–619.LinkGoogle Scholar
  • Sleight P, Redon J, Verdecchia P, Mancia G, Gao P, Fagard R, Schumacher H, et al. (2009) Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. J. Hypertension 27(7):1360–1369.CrossrefGoogle Scholar
  • Spruance SL, Reid JE, Grace M, Samore M (2004) Hazard ratio in clinical trials. Antimicrobial Agents Chemotherapy 48(8):2787–2792.CrossrefGoogle Scholar
  • Stewart IMcDG (1979) Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension. Lancet 313(8121):861–865.CrossrefGoogle Scholar
  • Tsika EP, Poulimenos L, Boudoulas KD, Manolis AJ (2014) The J-curve in arterial hypertension: Fact or fallacy? Cardiology 129(2):126–135.CrossrefGoogle Scholar
  • Wang Y, Taylor JMG (2001) Jointly modeling longitudinal and event time data with application to acquired immunodeficiency syndrome. J. Amer. Statist. Assoc. 96(455):895–905.CrossrefGoogle Scholar
  • Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, DePalma SM, et al. (2017) 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J. Amer. College Cardiology 71(6):e13–e115.Google Scholar
  • World Health Organization (2015) Global Status Report on Noncommunicable Disease 2014 (WHO, Geneva).Google Scholar
  • Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, et al. (2002) Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial. JAMA 288(19):2421–2431.CrossrefGoogle Scholar
  • Yousefi S, Balasubramanian M, Goldbaum MH, Medeiros FA, Zangwill LM, Weinreb RN, Liebmann JM, Girkin CA, Bowd C (2016) Unsupervised Gaussian mixture-model with expectation maximization for detecting glaucomatous progression in standard automated perimetry visual fields. Translational Vision Sci. Tech. 5(3):2.CrossrefGoogle Scholar
  • Zargoush M, Gümüş M, Verter V, Daskalopoulou SS (2018) Designing risk-adjusted therapy for patients with hypertension. Production Oper. Management 27(12):2291–2312.CrossrefGoogle Scholar
  • Zhang J, Denton BT, Balasubramanian H, Shah ND, Inman BA (2012) Optimization of prostate biopsy referral decisions. Manufacturing Service Oper. Management 14(4):529–547.LinkGoogle Scholar
  • Zillich AJ, Garg J, Basu S, Bakris GL, Carter BL (2006) Thiazide diuretics, potassium, and the development of diabetes. Hypertension 48(2):219–224.CrossrefGoogle Scholar
INFORMS site uses cookies to store information on your computer. Some are essential to make our site work; Others help us improve the user experience. By using this site, you consent to the placement of these cookies. Please read our Privacy Statement to learn more.